appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Aurobindo Pharma Ltd
AUROPHARMA
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs).
Brands
Brands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Increased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has increased by 1.35%
Recent NewsAll news
Aurobindo Pharma Facility Receives ‘Official Action Indicated’ Classification From USFDA
1 month ago•Bloomberg Quint
Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%
1 month ago•Business Standard
Raining Buybacks: 6 companies announce buybacks post Budget. More to follow?
1 month ago•Economic Times
Recent EventsAll events
Updates
Aurobindo Pharma Limited has informed the Exchange regarding 'New injectable facility of Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company, receives its first product approval by the United States Food and Drug Administration (US FDA)'. | Download
Aurobindo Pharma Limited has informed the Exchange regarding 'New injectable facility of Eugia Steriles Private Limited, a 100% stepdown subsidiary of the Company, receives its first product approval by the United States Food and Drug Administration (US FDA)'. | Download
Cash Dividend
Interim 2 • Div/Share: ₹ 1.5
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant